New results on an Alzheimer’s drug could mean more business for radiology and oncology company Akumin (Akumin Stock Quote, Charts, News, Analysts, Financials NASDAQ:AKU), according to Clarus Securities analyst Noel Atkinson. In an update to clients on Thursday, Atkinson maintained a “Buy” rating on the stock which rallied sharply over the summer. Drug makers Biogen […]
Vancouver-based WELL Health Technologies (WELL Health Technologies Stock Quote, Charts, News, Analysts, Financials TSX:WELL) received its first coverage by a US analyst this week with investment bankers Maxim Group starting WELL off with a “Buy” rating and $9.00 target price. In the initiation report, Maxim analyst Allen Klee said WELL has a profitable growth outlook […]
Share
Tweet
Share
